Manhattan Research Releases Physician Digital Media Planning Guide

Manhattan ResearchWhile most marketers have accepted that nearly all physicians are online today, the more difficult part is figuring out where to find these physicians on the World Wide Web. Finding the right promotional mix for connecting with physicians can be a challenging proposition, as physicians use third-party sites - such as the WebMD Professional Network, the New England Journal of Medicine, or specialty specific sites - more frequently than they use pharma-owned properties. As a result, brands realize that it is essential to connect with physicians through a variety of online professional resources - but figuring out where to find these physicians can prove difficult.

"Physician Digital Media Landscape: Connecting with Physicians Through Online Professional Resources," is part of Manhattan Research's ePharma Physician® market research and advisory service and provides a roadmap for physician marketers and media planners. The report explores the top professional medical websites, specialty sites, print and online medical journals, and professional email newsletters for primary care physicians, pediatricians, oncologists, cardiologists, gastroenterologists, infectious disease/HIV physicians, rheumatologists, and OB/GYNs. "Physician Digital Media Landscape" also includes interviews with industry experts, case studies, and a look at the future of physician marketing.

"This guide is an invaluable resource for anyone interested in understanding how physicians gather information online today," says Meredith Ressi, Vice President of Research at Manhattan Research. "Many companies are struggling to understand the appropriate promotional mix across the vast range of online resources used by physicians. This data shows the professional sources physicians rely on to gather professional medical information."

Report Outline
Title: Physician Digital Media Landscape: Connecting with Physicians through Online Professional Resources

Introduction
Physician Digital Media Outlook for Primary Care Physicians, Pediatricians, Oncologists, Cardiologists, Gastroenterologists, Infectious Disease/HIV Physicians, Rheumatologists, and OB/GYNs

  • Professional Medical Websites
  • Specialty Websites
  • Professional Journals
  • Professional Email Newsletters

Top Online Physician Professional Online Resource Summary

Physician Digital Media Outlook and Strategy

Conclusion and Key Takeaways

For an excerpt from the module and more information about its contents, please visit: www.manhattanresearch.com/products/Research_Modules/Physician/physician-digital-media-landscape.aspx

Access to the "Physician Digital Media Landscape" research module is immediately available to subscribers of Manhattan Research's ePharma Physician® v9.0 market research and strategic advisory service. For more information about subscribing to this service and gaining access to the in-depth physician market data and analysis, visit www.manhattanresearch.com/products/Strategic_Advisory/ePP.

About ePharma Physician® v9.0
ePharma Physician® v9.0 was conducted via online survey methodology in Q2 2009 among 1,517 online practicing U.S. physicians. Since 2002, the study has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit. ePharma Physician® gives insight to the physician digital resource and communication mix of over twenty specialist segments, including topics such as:

  • Product and corporate pharmaceutical websites
  • Specialty-specific sites, online journals, newsletters, and online conferences
  • Interactive detailing, live remote rep, customer service portals, and email communication
  • Web 2.0 technologies such as blogs, podcasts, wikis, and online communities

For additional product and subscription information, please visit www.manhattanresearch.com/products/Strategic_Advisory/ePP.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.decisionresourcesinc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...